Top

Journal of Cancer Survivorship

Published in:

01-12-2019 | Review

Computerized programs for cancer survivors with cognitive problems: a systematic review

Authors: Yoonjung Kim, Sook Jung Kang

Published in: Journal of Cancer Survivorship | Issue 6/2019

Abstract

Purpose

This study aimed to review and identify characteristics and lessons learned from studies on computerized cognitive interventions for cancer survivors (CSs) with cognitive dysfunction, exploring the content and results of interventions.

Methods

Studies were collected from the CINAHL, Web of Science, PubMed, and PsycINFO databases.

Results

Seven articles that met the inclusion criteria were included. Reviewed studies measured objective cognitive function, subjective cognitive function, and psychological aspects. Computerized interventions for CSs with cognitive decline were effective for executive function, memory, working memory, and speed of thought in the domain of objective cognitive function. Some subjective cognitive functions also showed significant improvement.

Conclusions

Computerized cognitive interventions have a positive impact on objective, subjective, and psychological aspects of cognitive problems. Further research needs to include more men as well as different cancer types. Programs also should include more than one target domain. Future researchers need to develop mobile applications that can effectively use computerized cognitive interventions.

Implications for Cancer Survivors

Results of this study should help provide optimal approaches to develop and apply effective computerized-cognitive-intervention programs. Health care providers need to be involved in these types of interventions and methods to encourage CSs to proactively practice cognitive-function training need to be developed.

Korea Central Cancer Registry. Annual report of cancer statistics in Korea in 2014. Seoul: Ministry of Health and Welfare; 2016.

Tager FA, McKinley PS, Schnabel FR, El-Tamer M, Cheung YK, Fang Y, et al. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Res Treat. 2010;123(1):25–34. https://doi.org/10.1007/s10549-009-0606-8.CrossRefPubMed

Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 2012;12(3):267–75. https://doi.org/10.1007/s11910-012-0264-9.CrossRefPubMed

Park JH, Bae SH, Jung YS, Jung YM. Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer. J Korean Acad Nurs. 2015;45(1):118–28. https://doi.org/10.4040/jkan.2015.45.1.118.CrossRefPubMed

Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004;100(11):2292–9. https://doi.org/10.1002/cncr.20272.CrossRefPubMed

Schmidt JE, Beckjord E, Bovbjerg DH, Low CA, Posluszny DM, Lowery AE, et al. Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey. J Cancer Surviv. 2016;10(2):302–11. https://doi.org/10.1007/s11764-015-0476-5.CrossRefPubMed

McDougall GJ Jr, Oliver JS, Scogin F. Memory and cancer: a review of the literature. Arch Psychiatr Nurs. 2014;28(3):180–6. https://doi.org/10.1016/j.apnu.2013.12.005.CrossRefPubMedPubMedCentral

Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev. 2012;38(7):926–34. https://doi.org/10.1016/j.ctrv.2012.05.002.CrossRefPubMed

Myers JS, Wick JA, Klemp J. Potential factors associated with perceived cognitive impairment in breast cancer survivors. Support Care Cancer. 2015;23(11):3219–28. https://doi.org/10.1007/s00520-015-2708-7.CrossRefPubMedPubMedCentral

10.

Lee JR, Oh PJ. Cognitive decline and quality of life among patients with breast cancer undergoing chemotherapy: the mediating effect of health promotion behavior. Korean J Adult Nurs. 2016;28(2):202–12. https://doi.org/10.7475/kjan.2016.28.2.202.CrossRef

11.

Asher A, Myers JS. The effect of cancer treatment on cognitive function. Clin Adv Hematol Oncol. 2015;13(7):441–50.PubMed

12.

Chan RJ, McCarthy AL, Devenish J, Sullivan KA, Chan A. Systematic review of pharmacologic and non-pharmacologic interventions to manage cognitive alterations after chemotherapy for breast cancer. Eur J Cancer. 2015;51(4):437–50. https://doi.org/10.1016/j.ejca.2014.12.017.CrossRefPubMed

13.

Craik FI, Winocur G, Palmer H, Binns MA, Edwards M, Bridges K, et al. Cognitive rehabilitation in the elderly: effects on memory. J Int Neuropsychol Soc. 2007;13(1):132–42. https://doi.org/10.1017/S1355617707070166.CrossRefPubMed

14.

Mowszowski L, Batchelor J, Naismith SL, Mowszowski L, Batchelor J, Naismith SL. Early intervention for cognitive decline: can cognitive training be used as a selective prevention technique? Int Psychogeriatr. 2010;22(4):537–48. https://doi.org/10.1017/S1041610209991748.CrossRefPubMed

15.

Vance DE, Frank JS, Bail J, Triebel KL, Niccolai LM, Gerstenecker A, et al. Interventions for cognitive deficits in breast cancer survivors treated with chemotherapy. Cancer Nurs. 2017;40(1):E11–27. https://doi.org/10.1097/NCC.0000000000000349.CrossRefPubMed

16.

Park J-H, Jung Y, Kim K, Bae SH. Effects of compensatory cognitive training intervention for breast cancer patients undergoing chemotherapy: a pilot study. Support Care Cancer. 2017;25(6):1887–96. https://doi.org/10.1007/s00520-017-3589-8.CrossRefPubMed

17.

Martin M, Clare L, Altgassen AM, Cameron MH, Zehnder F. Cognition-based interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev. 2011;1:CD006220. https://doi.org/10.1002/14651858.CD006220.pub2.CrossRef

18.

Clare L, Woods RT, Moniz Cook ED, Orrell M, Spector A. Cognitive rehabilitation and cognitive training for early-stage Alzheimer’s disease and vascular dementia. Cochrane Database Syst Rev. 2003;4:CD003260. https://doi.org/10.1002/14651858.CD003260.CrossRef

19.

Kueider AM, Parisi JM, Gross AL, Rebok GW. Computerized cognitive training with older adults: a systematic review. PLoS One. 2012;7(7):e40588. https://doi.org/10.1371/journal.pone.0040588.CrossRefPubMedPubMedCentral

20.

Yun YH, Lee KS, Kim YW, Park SY, Lee ES, Noh DY, et al. Web-based tailored education program for disease-free cancer survivors with cancer-related fatigue: a randomized controlled trial. J Clin Oncol. 2012;30(12):1296–303. https://doi.org/10.1200/JCO.2011.37.2979.CrossRefPubMed

21.

Arsham H. Interactive education: impact of the Internet on learning & teaching. 1995–2015. http://home.ubalt.edu/ntsbarsh/interactive.htm. Accessed July 27, 2017.

22.

Shin MJ, Park JE, Kim DR, Kim NR. The effect of computerized cognitive rehabilitation on cognitive function, activities of daily living and self-efficacy in brain injury patients. J Korean Soc Cog Rehabil. 2015;4(1):5–23.

23.

Jeong JH, Lee JM, Song SI. The effects of computerized cognitive rehabilitation program (Rehacom) on executive function in stroke patients. J Spec Educ Rehab. 2014;53(1):357–71.

24.

Song YW, Song AY, Kang SJ, Song JY, Choi HS, Jeong BJ. The effect of computerized cognition program (RehaCom) on the improvement of cognitive functions in patients with schizophrenia. J Korean Soc Cogn Rehab. 2015;4(1):65–79.

25.

Park JH, Kim MS. The effect of computerized executive function rehabilitation on the improvement of cognitive functions in patients with schizophrenia. Korean J Clin Psychol. 2015;34(1):37–60. https://doi.org/10.15842/kjcp.2015.34.1.003.CrossRef

26.

Von AD, Jansen CE, Allen DH. Evidence-based interventions for cancer—and treatment-related cognitive impairment. Clin J Oncol Nurs. 2014;18:17–25. https://doi.org/10.1188/14.CJON.S3.17-25.CrossRef

27.

Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.CrossRef

28.

Buchbinder D, Kelly DL, Duarte RF, Auletta JJ, Bhatt N, Byrne M, et al. Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and quality of life working committee of the CIBMTR and complications and quality of life working party of the EBMT. Bone Marrow Transplant. 2018;53(5):535–55. https://doi.org/10.1016/j.bbmt.2017.09.004.CrossRefPubMedPubMedCentral

29.

Mihuta ME, Green HJ, Shum DHK. Web-based cognitive rehabilitation for survivors of adult cancer: a randomised controlled trial. Psycho-Oncology. 2018;27(4):1172–9. https://doi.org/10.1002/pon.4615.CrossRefPubMed

30.

Bray VJ, Dhillon HM, Bell ML, Kabourakis M, Fiero MH, Yip D, et al. Evaluation of a web-based cognitive rehabilitation program in cancer survivors reporting cognitive symptoms after chemotherapy. J Clin Oncol. 2017;35(2):217–25. https://doi.org/10.1200/JCO.2016.67.8201.CrossRefPubMed

31.

Kesler S, Hadi Hosseini SM, Heckler C, Janelsins M, Palesh O, Mustian K, et al. Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors. Clin Breast Cancer. 2013;13(4):299–306. https://doi.org/10.1016/j.cibc.2013.02.004.CrossRefPubMedPubMedCentral

32.

Becker H, Henneghan AM, Volker DL, Mikan SQ. A pilot study of a cognitive-behavioral intervention for breast cancer survivors. Oncol Nurs Forum. 2017;44(2):255–64. https://doi.org/10.1188/17.ONF.255-264.CrossRefPubMed

33.

Von AD, Carpenter JS, Saykin A, Monahan P, Wu J, Yu M, et al. Advanced cognitive training for breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat. 2012;135(3):799–809. https://doi.org/10.1007/s10549-012-2210-6.CrossRef

34.

Poppelreuter M, Weis J, Bartsch HH. Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy. J Psychosoc Oncol. 2009;27(2):274–96. https://doi.org/10.1080/07347330902776044.CrossRefPubMed

35.

Damholdt MF, Mehlsen M, O’Toole MS, Andreasen RK, Pedersen AD, Zachariae R. Web-based cognitive training for breast cancer survivors with cognitive complaints—a randomized controlled trial. Psychooncology. 2016;25(11):1293–300. https://doi.org/10.1002/pon.4058.CrossRefPubMedPubMedCentral

36.

Bail J, Meneses K. Computer-based cognitive training for chemotherapy-related cognitive impairment in breast cancer survivors. Clin J Oncol Nurs. 2016;20(5):504–9. https://doi.org/10.1188/16.CJON.504-509.CrossRefPubMed

37.

Quesnel C, Savard J, Ivers H. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat. 2009;116(1):113–23. https://doi.org/10.1007/s10549-008-0114-2.CrossRefPubMed

38.

Morarji K, McArdle O, Hui K, Gingras-Hill G, Ahmed S, Greenblatt EM, et al. Ovarian function after chemotherapy in young breast cancer survivors. Curr Oncol. 2017;24(6):e494–502. https://doi.org/10.3747/co.24.3335.CrossRefPubMedPubMedCentral

39.

Oh PJ, Lee JR. Effect of cancer symptoms and fatigue on chemotherapy-related cognitive impairment and depression in people with gastrointestinal cancer. J Korean Acad Nurs. 2016;46(3):420–30. https://doi.org/10.4040/jkan.2016.46.3.420.CrossRefPubMed

40.

Treanor CJ, Li J, Donnelly M. Cognitive impairment among prostate cancer patients: an overview of reviews. Eur J Cancer Care. 2017;26. https://doi.org/10.1111/ecc.12642.CrossRef

41.

Hess LM, Huang HQ, Hanlon AL, Robinson WR, Johnson R, Chambers SK, et al. Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: an NRG oncology/gynecologic oncology group study. Gynecol Oncol. 2015;139(3):541–5. https://doi.org/10.1016/j.ygyno.2015.10.003.CrossRefPubMedPubMedCentral

42.

Vardy JL, Dhillon HM, Pond GR, Rourke SB, Bekele T, Renton C, et al. Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: a prospective, longitudinal, controlled study. J Clin Oncol. 2015;33(34):4085–92. https://doi.org/10.1200/JCO.2015.63.0905.CrossRefPubMedPubMedCentral

43.

Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer. 2011;19(10):1647–56. https://doi.org/10.1007/s00520-010-0997-4.CrossRefPubMed

44.

Choi EH, Chung BY, Kim GD, Kim KH, Byun HS. Literature review of cognitive developmental interventions on patients with breast cancer undergoing chemotherapy. J Korean Oncol Nurs. 2011;11(1):26–32. https://doi.org/10.5388/jkon.2011.11.1.26.CrossRef

45.

Henneghan A. Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review. Support Care Cancer. 2016;24(1):481–97. https://doi.org/10.1007/s00520-015-2927-y.CrossRefPubMed

46.

Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry. 2014;26(1):102–13. https://doi.org/10.3109/09540261.2013.864260.CrossRefPubMedPubMedCentral

47.

Kim YJ, Kang SJ. Impact of cognitive function and cancer coping on quality of life among women with post-chemotherapy breast cancer. Korean J Women Health Nurs. 2016;22(3):182–90. https://doi.org/10.4069/kjwhn.2016.22.3.182.CrossRef

48.

Becker H, Henneghan A, Mikan SQ. When do I get my brain back? Breast cancer survivors’ experiences of cognitive problems. Clin J Oncol Nurs. 2015;19(2):180–4. https://doi.org/10.1188/15.CJON.180-184.CrossRefPubMed

Title: Computerized programs for cancer survivors with cognitive problems: a systematic review
Authors: Yoonjung Kim
Sook Jung Kang
Publication date: 01-12-2019
Publisher: Springer US
Published in: Journal of Cancer Survivorship / Issue 6/2019
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-019-00807-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Implications for Cancer Survivors

Please log in to get access to this content

Other articles of this Issue 6/2019

Social attainment in survivors of pediatric central nervous system tumors: a systematic review and meta-analysis from the Children’s Oncology Group

Posttraumatic stress as a contributor to behavioral health outcomes and healthcare utilization in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study

Prevalence and factors associated with fear of recurrence in a mixed sample of young adults with cancer

Patient-clinician interactions and disparities in breast cancer care: the equality in breast cancer care study

Colorectal cancer survivors only marginally change their overall lifestyle in the first 2 years following diagnosis

Psychosocial interventions for cancer survivors: A meta-analysis of effects on positive affect

Keynote webinar | Spotlight on antibody–drug conjugates in cancer